SB 767

  • Tennessee Senate Bill
  • 111th Regular Session (2019-2020)
  • Introduced in Senate Feb 06, 2019
  • Senate
  • House
  • Governor

Controlled Substances - As introduced, permits a prescriber who is not a patient's obstetrical or gynecological provider to prescribe buprenorphine products to certain patients if the prescriber is a member of the same specialty practice group as the patient's obstetrical or gynecological provider. - Amends TCA Title 33; Title 53 and Title 63.

Votes


No votes to display

Actions


Feb 19, 2020

House

Returned to the Clerk's Desk.

Feb 12, 2020

House

Placed on s/c cal Mental Health & Substance Abuse Subcommittee for 2/19/2020

Apr 10, 2019

Senate

Assigned to General Subcommittee of Senate Health and Welfare Committee

Apr 04, 2019

Senate

Placed on Senate Health and Welfare Committee calendar for 4/10/2019

Apr 03, 2019

House

Action Def. in s/c Mental Health & Substance Abuse Subcommittee to First Calendar of 2020

Mar 27, 2019

House

Placed on s/c cal Mental Health & Substance Abuse Subcommittee for 4/3/2019

Feb 11, 2019

House

Assigned to s/c Mental Health & Substance Abuse Subcommittee

Feb 07, 2019

House

P2C, ref. to Health Committee

Senate

Passed on Second Consideration, refer to Senate Health and Welfare Committee

Feb 06, 2019

House

Intro., P1C.

Senate

Introduced, Passed on First Consideration

Feb 05, 2019

Senate

Filed for introduction

House

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.